Janux Therapeutics Inc. (JANX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Janux Therapeutics Inc.

NASDAQ: JANX · Real-Time Price · USD
24.00
0.69 (2.96%)
At close: Oct 03, 2025, 3:59 PM
24.21
0.88%
After-hours: Oct 03, 2025, 06:26 PM EDT

Janux Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
430.61M 19.2M 51.43M 35.58M
Short-Term Investments
594.57M 324.82M 275.59M 339.38M
Long-Term Investments
n/a n/a 816K 816K
Other Long-Term Assets
3.7M 3.33M 1.39M 392K
Receivables
5.38M 2.16M 700K 200K
Inventory
n/a n/a -700K -200K
Other Current Assets
n/a n/a 5.42M n/a
Total Current Assets
1.03B 349.24M 332.44M 377.02M
Property-Plant & Equipment
24.15M 27.84M 29.36M 1.6M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
27.85M 31.17M 31.57M 2.81M
Total Assets
1.06B 380.41M 364.01M 379.82M
Account Payables
4.03M 2.42M 2.16M 2.46M
Deferred Revenue
n/a 1.71M 5.41M 5.16M
Short-Term Debt
1.75M n/a n/a 194K
Other Current Liabilities
9.94M 3.3M 5.51M 3.62M
Total Current Liabilities
17.46M 13.03M 16.51M 12.8M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
21.28M 23.02M 26.76M 700K
Total Liabilities
38.73M 36.06M 43.27M 13.5M
Total Debt
23.02M 24.54M 25.3M 194K
Book Value
1.02B 344.35M 320.74M 366.33M
Book Value Per Share
19.03 7.82 7.73 8.88
Common Stock
59K 46K 42K 41K
Retained Earnings
-237.76M -168.76M -110.47M -47.41M
Comprehensive Income
2.16M 665K -1.53M -270K
Shareholders Equity
1.02B 344.35M 320.74M 366.33M
Total Investments
594.57M 324.82M 275.59M 339.38M